GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSFF) » Definitions » Sale Of Business

OSSFF (Embla Medical hf) Sale Of Business : $0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf Sale Of Business?

Embla Medical hf's sale of business for the three months ended in Dec. 2024 was $0.0 Mil. It means Embla Medical hf gained $0.0 Mil from selling business. Embla Medical hf's sale of business for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.

Compared with last quarter ($0.0 Mil in Sep. 2024 ), Embla Medical hf gained the same money from selling business in Dec. 2024 ($0.0 Mil).


Embla Medical hf Sale Of Business Historical Data

The historical data trend for Embla Medical hf's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Sale Of Business Chart

Embla Medical hf Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Embla Medical hf Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Embla Medical hf Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf Sale Of Business Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

From GuruFocus

Q1 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Embla Medical hf: Interim Report Q2 2024

By PRNewswire 07-23-2024

Q1 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 10-09-2024

Q2 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Embla Medical hf: Interim Report Q3 2024

By PRNewswire 10-22-2024

Full Year 2019 Ossur hf Guidance Call Transcript

By GuruFocus Research 02-14-2024

Embla Medical hf: Interim Report Q4 2024

By PRNewswire 02-05-2025

Preliminary Q2 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024